AIM
PDLI

Assured Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Assured Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-66,086
Closed -$246K – 1115
2019
Q1 		$246K Buy
66,086
+2,029
+3% +$6.85K ﹤0.01% 761
2018
Q4 		$186K Buy
+64,057
New +$176K 0.01% 890
2014
Q2 		– Sell
-87,346
Closed -$726K – 281
2014
Q1 		$726K Buy
+87,346
New +$749K 0.01% 234

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Assured Investment Management's PDLI Position: Q2 2019 in Review

Assured Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 66,086 shares — an estimated $246K sold.

Assured Investment Management first reported a position in PDLI in Q1 2014 and held it in 3 quarters. The position peaked at $726K in Q1 2014. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

  • Assured Investment Management reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 66,086 PDL BioPharma, Inc. shares in Q2 2019, an estimated $246K.
  • Assured Investment Management first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 3 quarters.
  • Assured Investment Management's PDL BioPharma, Inc. position peaked at $726K in Q1 2014.
  • 148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.